A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

Conditions:   Influenza;   Swine-origin A/H1N1 InfluenzaInterventions:   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)Sponsors:   Sanofi;   Sanofi Pasteur, a Sanofi CompanyCompleted - verified January 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials